Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Viviane C. Cahen"'
Autor:
Jyotinder N. Punia, Maurice R.G. O'Gorman, Karen R. Rabin, Richard Sposto, Gerald Wertheim, Viviane C. Cahen, Terri Guinipero, William G. Woods, Reuven J. Schore, Dragos C. Luca, Etan Orgel, Matthew J. Oberley, Jemily Malvar, Alix E. Seif, Sunil S. Raikar
Publikováno v:
Leukemia
The rarity of mixed phenotype acute leukemia (MPAL) has precluded adequate data to incorporate minimal residual disease (MRD) monitoring into therapy. Fluidity in MPAL classification systems further complicates understanding its biology and outcomes;
Autor:
Jennifer J. Wilkes, Yuan-Shung V. Huang, Tamara P. Miller, Alix E. Seif, Amanda M. DiNofia, Karen R. Rabin, Kelly D. Getz, Lena E. Winestone, Brian T. Fisher, Yimei Li, Richard Aplenc, Caitlin W Elgarten, Viviane C. Cahen, M. Monica Gramatges
Publikováno v:
Pediatric Blood & Cancer. 68
Introduction Our objectives were to design and validate methods to identify relapse and hematopoietic stem cell transplantation (HSCT) in children with acute lymphoblastic leukemia (ALL) using administrative data representing hospitalizations at US p
Autor:
Jamie L. Duke, Susan McClory, Dimitri S. Monos, Kelly D. Getz, Nancy Bunin, Mark Ramos, Yimei Li, Viviane C. Cahen, Alix E. Seif
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S186
Graft versus host disease (GVHD) causes significant morbidity and mortality after allogeneic stem cell transplant (SCT). Little is known about genetic determinants of GVHD risk, including human leukocyte antigen (HLA) genotypes outside of HLA-mismatc
Autor:
Naomi J. Winick, Meenakshi Devidas, Eric C. Larsen, Richard Aplenc, William L. Carroll, Matthew Hall, Yuan-Shung Huang, Brian T. Fisher, Alix E. Seif, Yimei Li, Amanda M. DiNofia, Viviane C. Cahen, Stephen P. Hunger
Publikováno v:
Cancer Medicine
The Children's Oncology Group (COG) develops and implements multi‐institutional clinical trials with the primary goal of assessing the efficacy and safety profile of treatment regimens for various pediatric cancers. However, the monetary costs of t
Autor:
Yuan-Shung Huang, Brian T. Fisher, Richard Aplenc, Karen R. Rabin, Kelly D. Getz, Jennifer J. Wilkes, Viviane C. Cahen, Yimei Li, Lena E. Winestone, Amanda M. DiNofia, M. Monica Gramatges, Alix E. Seif, Caitlin W Elgarten
Publikováno v:
Blood. 132:624-624
Administrative databases can be used to study outcomes including patients outside of clinical trials and have been used to identify relapse and HSCT in adult and adolescent/young adult leukemia populations. However, there are no published studies usi
Autor:
Jennifer J. Wilkes, Lena E. Winestone, Caitlin W Elgarten, Yuan-Shung Huang, M. Monica Gramatges, Brian T. Fisher, Amanda M. DiNofia, Karen R. Rabin, Richard Aplenc, Kelly D. Getz, Viviane C. Cahen, Julie C. Fitzgerald, Evanette Burrows, Alix E. Seif, Yimei Li
Publikováno v:
Blood. 132:3597-3597
Infectious complications are major contributors to morbidity and mortality in children with leukemia; however, clinical trial reporting is incomplete (Miller 2016 J Clin Oncol). Using administrative data to identify SS events could improve estimates